Investigation of the pathogenesis of autoimmune vitiligo and the regulatory mechanism of HLA-A expression

Investigation of the pathogenesis of autoimmune vitiligo and the regulatory mechanism of HLA-A expression - Investigation of the pathogenesis of autoimmune vitiligo and the regulatory mechanism of HLA-A expression

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021022

Enrollment

Registered

2016-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo vulgaris

Interventions

The peripheral blood is taken from Japanese volunteers. Genomic DNA is extracted from blood and significant SNPs for vitiligo risk are genotyped. The volunteers are classified into two groups, and sub

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: No specific condition is needed.

Exclusion criteria

Exclusion criteria: No specific exclusion is needed.

Design outcomes

Primary

Measure	Time frame
Measurement of HLA-A mRNA and the activity of HLA-A regularoty region using peripheral blood of Japanese volunteers.	—

Countries

Japan

Contacts

Public ContactMasahiro Hayashi

Yamagata University School of Medicine Department of Dermatology

czk11223@nifty.ne.jp023-628-5361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026